Hsbc Holdings PLC Sells 3,563 Shares of Exponent, Inc. (NASDAQ:EXPO)

Hsbc Holdings PLC cut its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 23.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,408 shares of the business services provider’s stock after selling 3,563 shares during the period. Hsbc Holdings PLC’s holdings in Exponent were worth $1,091,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in EXPO. GAMMA Investing LLC lifted its holdings in Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after acquiring an additional 153 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in Exponent by 866.0% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock worth $42,000 after acquiring an additional 459 shares in the last quarter. Whittier Trust Co. of Nevada Inc. lifted its holdings in Exponent by 166.5% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock worth $49,000 after acquiring an additional 323 shares in the last quarter. Janiczek Wealth Management LLC lifted its holdings in Exponent by 293.7% during the first quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock worth $52,000 after acquiring an additional 467 shares in the last quarter. Finally, YHB Investment Advisors Inc. acquired a new stake in shares of Exponent in the 1st quarter valued at about $75,000. 92.37% of the stock is currently owned by institutional investors.

Exponent Price Performance

EXPO opened at $113.25 on Friday. The business’s 50-day moving average price is $106.22 and its two-hundred day moving average price is $95.80. Exponent, Inc. has a 1 year low of $64.61 and a 1 year high of $114.67. The company has a market capitalization of $5.74 billion, a price-to-earnings ratio of 57.20 and a beta of 0.66.

Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.07. Exponent had a return on equity of 28.39% and a net margin of 19.35%. The firm had revenue of $132.43 million for the quarter, compared to the consensus estimate of $130.83 million. During the same quarter last year, the business posted $0.50 EPS. The company’s revenue for the quarter was up 2.1% on a year-over-year basis. Sell-side analysts anticipate that Exponent, Inc. will post 2.04 earnings per share for the current fiscal year.

Exponent Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 20th. Investors of record on Friday, September 6th were given a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date was Friday, September 6th. Exponent’s dividend payout ratio is currently 56.57%.

Analyst Upgrades and Downgrades

Separately, Truist Financial reissued a “buy” rating and issued a $120.00 price target (up previously from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Insider Activity at Exponent

In related news, VP John Pye sold 3,956 shares of Exponent stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the sale, the vice president now owns 28,422 shares of the company’s stock, valued at $2,984,310. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.10% of the stock is owned by company insiders.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.